期刊文献+

预处理方案包含大剂量氟达拉滨的自体外周血干细胞移植治疗非霍奇金淋巴瘤一例

原文传递
导出
摘要 患者 女,42岁,体重80kg,体表面积1.8 m2,因"左面部肿胀8个月,左耳后肿块2个月"于2003年5月9日入院.行左眼睑皮肤活检示:小淋巴细胞性淋巴瘤;骨髓穿刺结果:增生性骨髓象,可见幼稚淋巴细胞及其分裂象,比例占核细胞的1.5%;
出处 《白血病.淋巴瘤》 CAS 2008年第2期-,共2页 Journal of Leukemia & Lymphoma
  • 相关文献

参考文献6

  • 1Ross SR,McTavish D,Faulds D Fludarabine. A review of its pharmacological properties and therapeutic potential in malignancy[J].Drugs,1993,(05):737-759.doi:10.2165/00003495-199345050-00009.
  • 2Gandhi V,Plunkett W. Cellular and clinical pharmacology of fludarabine[J].Clinical Pharmacokinetics,2002,(02):93-103.doi:10.2165/00003088-200241020-00002.
  • 3Zinzani PL. Clinical experience with fludarabine in indolent non-Hedgkin's lymphoma[J].HEMATOLOGY JOURNAL,2004,(Z1):S38-S49.
  • 4Velasquez WS,Lew D,Grogan TM. Combination of fludarabine and mitoxantrone in untreated stages Ⅲ and Ⅳ low-grade lymphoma:S9501[J].Journal of Clinical Oncology,2003,(10):1996-2003.doi:10.1200/JCO.2003.09.047.
  • 5Ma SY,Au WY,Chim CS. Fludarabine,mitoxantrone and dexamethasone in the treatment of indolent B-and T-cell lymphoid malignancies in chinese patients[J].British Journal of Haematology,2004,(06):754-761.doi:10.1111/j.1365-2141.2004.04852.x.
  • 6黄慧强,姜文奇,彭玉龙,夏忠军,李宇红,林旭滨,林桐榆,孙晓菲,管忠震.氟达拉滨治疗恶性淋巴瘤29例报告[J].癌症,2004,23(4):448-451. 被引量:9

二级参考文献11

  • 1Pier Luigi Zinzani,Massimo Magagnoli,Luciano Moretti,et al. Randomized Trial of Fludarabine Versus Fludarabine and Idarubicin as Frontline Treatment in Patients With Indolent or Mantle-Cell Lymphoma [J]. J Clin Oncol, 2003,18:773- 779.
  • 2Redman JR,Cabanillas F,Velaquez WS,et al. Phase Ⅱ trial of fludarabine phosphate in lymphoma:AN effective new agent in low-grade lymphoma [J]. J Clin Oncol,1992,10:790- 794.
  • 3Hochster HS,Kim KM,Green MD,et al. Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma:Resulta ofan Eastern Cooperative Oncology Group study [J].J Clin Oncol,1992,10:28- 32.
  • 4Zinzani PL,Lauria F,Rondelli D,et al. Fludarabine:An active agent in treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma [J]. Ann Oncol,1993,4:575- 578.
  • 5Hiddeman W,Unterhalt M,Pott C,et al. Fludarabine single-agent therapy for relapsed low-grade non-Hodgkin's lymphoma:A phase Ⅱ study of the German low-grade Non-Hodgkin's lymphoma study Group [J]. Semin Oncol,1993,20:28- 31.
  • 6Mclaughlin P,Hagemeister FB, Swan F, et al. Phase Ⅰ study of the combination of Fludarabine,Mitoxantrone and dexamethasone in low-grade lymphoma [J]. J Clin Oncol,1994,12:575- 579.
  • 7Mclaughlin P,Hagemeister FB,Romaguera JE, et al. Fludarabine,Mitoxantrone and dexamethasone:An effective new regimen for indolent lymphoma [J]. J Clin Oncol,1996,14:1262- 1268.
  • 8Zinzani PL,Bendandi M, Magagnoli M,et al. Fludarabine-mitoxantrone:combination-containing regimen in recurrent low-grade non-Hodgkin's lymphomas [J]. Ann Oncol, 1997,8:379- 383.
  • 9William S, Velasquez,Danika Lew,et al. Combination of Fludarabine and Mitoxantrone in Untreated Stages Ⅲ and Ⅳ Low-Grade Lymphoma:S9501 [J]. J Clin Oncol,2003,21:1996- 2003.
  • 10Tsimberidou AM,Mclaughlin P,Younes A,et al. Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage Ⅳ indolent lymphoma [J]. Blood,2002,100:4351- 4357.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部